Publications by authors named "R Beuk"

Dendritic cells have been investigated for cell-based immunotherapy for various applications. The low abundance of dendritic cells in blood hampers their clinical application, resulting in the use of monocyte-derived dendritic cells as an alternative cell type. Limited knowledge is available regarding blood-circulating human dendritic cells, which can be divided into three subsets: type 2 conventional dendritic cells, type 1 conventional dendritic cells, and plasmacytoid dendritic cells.

View Article and Find Full Text PDF
Article Synopsis
  • - Cholesterol embolization syndrome is a serious and often overlooked complication that can occur after procedures like endovascular interventions or thrombolytic therapies, leading to serious health issues involving abdominal organs and skin.
  • - In this reported case, the patient experienced severe skin ulceration and necrosis following treatment, eventually resulting in the amputation of both legs after unsuccessful initial interventions.
  • - Despite treatment efforts, including prednisone, the patient died from sepsis and renal failure, highlighting the need for timely diagnosis and management of cholesterol embolization syndrome in patients with increasing skin necrosis even after successful arterial revascularization.
View Article and Find Full Text PDF

Objective: The new 2019 guideline of the European Society for Vascular Surgery (ESVS) recommends consideration for elective iliac artery aneurysm (eIAA) repair when the iliac diameter exceeds 3.5 cm, as opposed to 3.0 cm previously.

View Article and Find Full Text PDF

Background: Chronic mesenteric ischemia (CMI) is characterized by long-standing abdominal symptoms due to insufficient mesenteric circulation. Data on the effect of revascularisation on quality of life (QoL) for CMI are scarce. This study is the first to evaluate the impact of revascularisation on quality of life.

View Article and Find Full Text PDF

: To evaluate the efficacy and treatment rationale of Hürthle cell carcinoma (HCC) following a patient with progressive and metastatic HCC. HCC was recently shown to harbor a distinct genetic make-up and the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kiase (PI3K)/AKT signaling pathways are potential targets for anti-cancer agents in the management of recurrent HCC. The presence or absence of gene variants can give a rationale for targeted therapies that could be made available in the context of drug repurposing trials.

View Article and Find Full Text PDF